News

Healing Realty Trust Announces Preferred Real Estate Partnership Agreements with NeuroSpa, Cambridge Biotherapies and Cathexis to Enhance Clinic-Focused Portfolio

Jupiter, Florida--(Newsfile Corp. - August 6, 2024) - Healing Realty Trust ("HRT" or the "Company"), a data-driven, self-managed real estate…

1 year ago

Bemax Inc. Signs Letter of Intent to Acquire Kona Gold, LLC

Strategic Acquisition to Strengthen Bemax's Consumer Packaged Goods Portfolio and Drive Market GrowthDallas, Georgia--(Newsfile Corp. - August 6, 2024) -…

1 year ago

InspireMD Reports Second Quarter 2024 Financial Results and Provides Business Update

- Announced positive outcomes from the C-GUARDIANS IDE clinical trial of the CGuard™ Prime carotid stent system demonstrating a one-year…

1 year ago

Phio Pharmaceuticals Announces Exploratory Collaboration with a Luxury Skin Care Company for Phio’s Patented INTASYL Compound

Phio's INTASYL compound targets aging skin disordersMarlborough, Massachusetts--(Newsfile Corp. - August 6, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a…

1 year ago

TFF Pharmaceuticals Provides Continued Positive Outcomes from Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection

Patient enrollment has accelerated, now with 13 patients enrolled in trial TFF TAC at ~20% of the oral tacrolimus dose…

1 year ago

Mersana Therapeutics to Host Second Quarter 2024 Conference Call on August 13, 2024

CAMBRIDGE, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering…

1 year ago

Cosmos Health Reports Full Year 2023 Results: Revenue Increases to $53.4M, or 6% YoY; Stockholders’ Equity Remains Near Record Highs at $36M, or $2.25 per Share

CHICAGO, IL / ACCESSWIRE / August 6, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…

1 year ago

Annovis’ Lead Compound Enhances Cognition Synergistically with GLP-1 Agonist

Figure 1 Combination of dulaglutide (Trulicity®) and buntanetap improves memory and synaptic plasticity in AD mice (*p<0.05, **p<0.01). Figure 2…

1 year ago

Science 37 Unveils New Corporate Headquarters in Research Triangle Park, NC

19,000-square-foot facility reflects the company’s recent growth and continued commitment to the regionMORRISVILLE, N.C., Aug. 06, 2024 (GLOBE NEWSWIRE) --…

1 year ago

Corbus Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Corporate Update

Clinical update presented at ASCO 2024 for CRB-701 showed continued differentiated safety and encouraging efficacy in patients with metastatic urothelial…

1 year ago